Pharmaceutical service provider PharmaLex has expanded its European operations with the launch of a new office in Paris, France.
The firm, which merged with YES Pharma Services in October last year, will now offer its pharmacovigilance and regulatory affairs consulting expertise to the French pharmaceutical industry and looks to grow its local presence in the area.
Dr Thomas Dobmeyer, co-chief executive officer of PharmaLex, said: “For the pharmaceutical industry, France plays a significant role on an international level.
“It is of great importance and strategic interest to be able to service this highly thriving market.”
Leading the new subsidiary are Sophie Guillaume and Patrick Larcier, as general manager and senior director for drug development and vigilance, respectively.
Guillaume commented: “Together with Patrick Larcier, I am excited to have planted the seed for PharmaLex in France.
“We will grow our local presence in close cooperation with our international colleagues, allowing us to provide highest standards of quality of all services from the very beginning.”